Introduction: Spinal cord injury (SCI) is a dramatic medical pathology consequence of a trauma (primary injury). However, most of the post traumatic degeneration of the tissue is caused by the so-called secondary injury, which is known to be a multifactorial process. This, indeed, includes a wide spectrum of events: blood brain barrier dysfunction, local inflammation, neuronal death, demyelination and disconnection of nerve pathways. Areas covered: Cell therapy represents a promising cure to target diseases and disorders at the cellular level, by restoring cell population or using cells as carriers of therapeutic cargo. In particular, regenerative medicine with stem cells represents the most appealing category to be used, thanks to their peculiar features. Expert opinion: Many preclinical research studies demonstrated that cell treatment can improve animal sensory/motor functions and so demonstrated to be very promising for clinical trials. In particular, recent advances have led to the development of biomaterials aiming to promote in situ cell delivery. This review digs into this topic discussing the possibility of cell treatment to improve medical chances in SCI repair.
Adenocarcinoma of the colon is the most common malignant neoplasia of the gastrointestinal tract and is a major contributor to mortality worldwide. Invasiveness and metastatic behavior are typical of malignant tumors and, because of its portal drainage, the liver is the closest capillary bed available in this case, hence the common site of metastatic dissemination. Current therapies forecast total resection of primary tumor when possible and partial liver resection at advanced stages, along with systemic intravenous therapies consisting of chemotherapeutic agents such as 5-fluorouracil. These cures are definitely not exempt from drawbacks and heavy side effects. Biocompatible polymeric networks, both in colloids and bulk forms, able to absorb large quantities of water and load a variety of molecules-belong to the class of innovative drug delivery systems, thus suitable for the purpose and tunable on each patient can represent a promising alternative. Indeed, the implantation of polymeric scaffolds easy to synthesize can substitute chemotherapy and combination therapies scheduling, shortening side effects. Moreover, they do not require a surgical removal thanks to spontaneous degradation and guarantees an extended and regional cargo release, maintaining high drug concentrations. In this review, we focus our attention on the key role of polymeric networks as drug delivery systems potentially able to counteract this dramatic disease.
Emulsions play a crucial part in the whole beauty and care market, especially in skin and hair care domains where, due to their extraordinary versatility, they represent most of the finite products. Being thermodynamically unstable, one key aspect of their formulation is the use of stabilizers that ensure a long lifetime under different conditions. In this framework a key role is related to rheology modifiers, which include all those raw ingredients added to achieve, among others, desirable inflow characteristics that would not be possible to gain in their absence. In this review, strong attention was dedicated to different polymers and formulation strategies to understand the key role of these ingredients, widely used in emulsion-based cosmetics formulations.
Spinal cord injury (SCI) is an injurious process that begins with immediate physical damage to the spinal cord and associated tissues during an acute traumatic event. However, the tissue damage expands in both intensity and volume in the subsequent subacute phase. At this stage, numerous events exacerbate the pathological condition, and therein lies the main cause of post-traumatic neural degeneration, which then ends with the chronic phase. In recent years, therapeutic interventions addressing different neurodegenerative mechanisms have been proposed, but have met with limited success when translated into clinical settings. The underlying reasons for this are that the pathogenesis of SCI is a continued multifactorial disease, and the treatment of only one factor is not sufficient to curb neural degeneration and resulting paralysis. Recent advances have led to the development of biomaterials aiming to promote in situ combinatorial strategies using drugs/biomolecules to achieve a maximized multitarget approach. This review provides an overview of single and combinatorial regenerative-factor-based treatments as well as potential delivery options to treat SCIs.
In the last years, nanogels have emerged as one of the most promising classes of novel drug delivery vehicles since they can be employed in multiple fields, such as various therapeutics or diagnostics, and with different classes of compounds and active molecules. Their features, such as a high volume to surface ratio, excellent drug loading and release ability, as well as biocompatibility and tunable behavior, are unique, and, nowadays, great efforts are made to develop new formulations that can be employed in a wider range of applications. Polyethylene glycol (PEG)-polyethylenimine (PEI) nanogels probably represent the baseline of this class of biomaterials and they are still largely employed and studied. In any way, the possibility to exploit new core formulations for nanogels is certainly very interesting in order to understand the influence of different polymer chains on the final properties of the system. In this research, we explore and make a comparison between PEG-PEI nanogels and two other different formulations: pluronic F127-PEI nanogels and PEG-Jeffamine nanogels. We propose nanogels synthesis methods, their chemical and physical characterization, as well as their stability analysis, and we focus on the different drug delivery ability that these structures exhibit working with different typologies of drug mimetics.
24 July 2021 in International Journal of Polymeric Materials and Polymeric Biomaterials
Drug delivery systems for the controlled and targeted release of drugs are in continuous development nowadays, allowing to benefit of ever better and more effective therapies. Chemical engineers thanks to their multidisciplinary preparation ranging from a thorough knowledge of transport phenomena to the transformations of matter, play a fundamental role in the development of these innovative systems. In this work, we developed and characterized some innovative polymer-based hydrogels, to study their efficacy as systems for controlled release of drugs and to verify the possibility of inherent antimicrobial properties for these hydrogels. We report here the use of two different Carbomer-based formulations, particularly promising for their simplicity and potential applications. In the first case, polyethylene glycol was used as the cross-linking agent and the material was obtained through a physical-chemical transition by microwave irradiation. In the other case, a polyetherdiamine was employed and the reticulation was achieved by chemical transformation with the use of a specific coupling agent. The materials were characterized in their structure, swelling behavior, rheological properties, morphology and antimicrobial activity. Finally, the effectiveness of these formulations as systems for the controlled release of drugs was tested using mimetic drugs of various sizes.